TS DOST 2025 Phase 1 seat allotment results will be out on May 29, 2025. The steps to check is given here, (HT file) Also read: AP EAMCET 2025 Answer Key: Objection window for A&P closes today at ...

Kymera Therapeutics reported positive results from its phase 1 healthy volunteer study using KT-621. Click here to find out why KYMR stock is a Strong Buy.

This double-blind, randomized, placebo-controlled Phase 1 SAD study evaluated the safety, tolerability, and pharmacokinetics of TIX100 at escalating doses in 28 healthy adults.

Mersana’s ongoing Phase 1 trial of Emi-Le is enrolling TNBC patients who have undergone one to four prior treatments, including at least one topoisomerase-1 inhibitor ADC.

Repeated doses of INB-200 demonstrate extended median progression-free survival (mPFS) of 16.1 months, more than double the expected 6.9 months typically observed with the standard-of-care (SOC ...

The Phase 1/2a study will be conducted in the U.S., with the potential to expand globally, and will evaluate the safety and efficacy of VS-7375 in patients with advanced KRAS G12D mutant solid tumors.

DF-003 has completed a Phase 1 clinical trial (NCT05997641) in normal healthy volunteers and is now accruing patients with ROSAH syndrome in a Phase 1b trial (NCT06395285).

Once state track concludes, Phase 2 begins. Those renovations include widening the field and expanding to a 9-lane track. That is expected to be completed by the end of the calendar year.

Sagimet has initiated a Phase 1 first-in-human clinical trial for a second FASN inhibitor, TVB-3567, indicating a commitment to expanding its pipeline in acne treatment.

SHANGHAI & CAMBRIDGE, Mass., June 02, 2025--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that updated data from an ongoing, global Phase 1a/1b clinical trial (NCT06179069) evaluating ...

In previous results from the phase 1/2 MonumenTAL-1 study (CCO Jan 2024; median follow-up [mFU] 20–30 mo), Tal elicited deep, durable responses with low discontinuation rates. We report efficacy and ...